Proactive Investors - Run By Investors For Investors

Next shares surge as the fashion retailer lifts full-year estimates

Next said it expects the external environment to remain difficult but its prospects going forward appear "somewhat less challenging" than they did six months ago
Next said the clothing market remains challenging

Next Plc (LON:NXT) reported a decline in first-half profits and sales but shares jumped as it raised its full year guidance after reining in costs to offset the effects of rising inflation.

In the six months to July, profit before tax dropped 9.5% to £309.3mln from the same period a year ago and total group sales fell 2.2% to £1.9bn.

Next’s own-brand full price sales edged down 1.2% and total sales, including markdowns, fell 2.3% to £1.8bn.  

In its retail division, full price sales decreased 7.7% and total sales were down 8.3% to £993mln.

The Next Directory catalogue shopping arm saw full price sales growth of 7.4% and a total sales increase of 5.7% to £868.4mln as the number of active customers rose 4% to 4.9 million.

The number of customers using cash to pay for items rose 11% to 1.50mln, compared to Next’s credit account, which saw customers using this service broadly unchanged at 2.49mln.

“While the high street business continues to splutter, Next’s Directory divisions seems to have turned the corner," said George Salmon, equity analyst at Hargreaves Lansdown.

"The sunny weather of the last few months is lending a helping hand, but the decision to spend £11mln on refreshing the website, including the recruitment of 121 extra systems and marketing staff, looks like it is paying off."

WATCH: Next warming up after summer boost to second quarter performance

Consumer squeeze 

Next blamed the weak sales on the consumer squeeze from falling disposable incomes. A slump in the pound since the Brexit vote has pushed inflation higher while wages rises have failed to keep up with rising prices.

In an effort to offset an increase in cost inflation Next expects to achieve cost savings of £29mln in the year to January 2018.

“Cost control remains at the heart of the business and we remain determined that cost savings must come through innovation and efficiency, rather than any compromise to our product quality or services,” the company said.

The group said it expects price inflation to “work its way out of the system” next year as the effects of the one-off Brexit devaluation of the pound starts to annualise.

Next sees price rises of no more than 2% and no price rises at all in the second half of 2018.

Next raises full year estimates

Full price sales in the second half of the year are now expected to be in the range of a 2.8% fall and 3.8% rise, after seeing an improvement in the past three months on the back of product improvements and favourable weather.

Subsequently Next has upgraded its full year estimates for full price sales to a range of a 2.0% decline and a 1.5% increase, from the 3.0% drop to a 0.5% gain it predicted in August. 

Next raised its guidance on full year pre-tax profits to a range of £687mln to £747mln from a previous estimate of £680mln to £740mln.

However, the retailer warned:  “The wider economic environment, clothing market and High Street look as challenging as ever, and we do not underestimate the task of managing our stores through a period of prolonged negative like-for-like sales.”

“Nonetheless, we believe our stores will remain cash generative for many years to come and represent an important asset for the group.”

While it expects the external environment to remain difficult, Next said its prospects going forward appear "somewhat less challenging" than they did six months ago.

Shore Capital reiterated a 'hold' rating and target price of 4,417p.

"We believe today's more confident outlook from management and upgraded guidance is likely to act as a stimulus for share price appreciation however there are still long-term issues for the company to address," said analyst George Mensah.

"Investors can take comfort that management has, in our view, taken a more proactive approach in addressing such issues and we believe this is a factor in the improved outlook reflected in today's statement."

Surplus cash to be returned via share buybacks

Next expects to generate about £53mln of surplus cash above the £257mln it had said it intended to distribute to shareholders through four special dividends of 45p per share.

Two of the special dividend payments have made in the year to date and a third has been declared and will be paid to eligible shareholders on 1 November 2017.  

The additional £53mln will be returned to shareholders through share buybacks in the second half subject to the share price and market conditions.  

Next left its ordinary interim dividend unchanged at 53p each.

Shares surged 10.12% to 4,873p in early trading. 

UBS said: "With the beat to our first half estimate, good momentum into the third quarter and the guidance raise, we add £10mln to our fiscal year pre-tax profit estimate, taking us circa 1% above guidance midpoint but still comfortably within the range.We assume -8% second half retail like-for-like (first half -10%) and second half Directory full price sales growth of 7% (in line with first half)."

The bank said the main risks relate to Black Friday promotions, fourth quarter ranges and the weather.

"Momentum should also be good into the first quarter of 2019 but some industry capacity reduction is needed at some stage to take the pressure off if the market remains under pressure."

View full NXT profile View Profile

Next Plc Timeline

February 14 2018
February 13 2018
February 12 2018
February 08 2018
February 07 2018
February 06 2018
February 05 2018
February 02 2018

Related Articles

H&T Pawnbrokers store
November 15 2017
“We have delivered a strong trading performance during the second half in the key segments of Pawnbroking, Retail and Personal Loans”
Medical tests
July 11 2017
In an operational update, the medical services and software company said a multi-centre investigator led study comprising data from 607 patients at two academic university hospitals has now been completed

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use